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Abstract
Background: The role of non-infective inflammatory response (IR) in the aetiology of postoperative cognitive
dysfunction (POCD) is still controversial. The aim of this controlled, prospective observational study was to assess
the possible relationship between the grade of IR, defined by procalcitonin (PCT) changes, and development of
POCD related to cardiac surgery.
Methods: Forty-two patients, who were ≥ 60 years of age and scheduled for elective cardiac surgery, were separated
into the low inflammatory (LIR) and high inflammatory (HIR) response groups based on their PCT levels measured
on the first postoperative day. A matched normative control group of 32 subjects was recruited from primary care
practice. The PCT and C-reactive protein (CRP) levels were monitored daily during the first five postoperative days. The
cognitive function and mood state were preoperatively tested with a set of five neurocognitive tests and two mood
inventories and at the seventh postoperative day. The Reliable Change Index modified for practice (RCIp) using data
from normative controls was applied to determine the significant decline in test performance.
Results: The LIR (n = 20) and HIR (n = 22) groups differed significantly in the PCT (p < 0.001) but not in the CRP time
courses. The incidence of POCD at the first postoperative week was 35.7% in the cohort. The LIR and HIR groups did
not vary in the RCIp Z scores of neurocognitive tests and frequencies of POCD (7 vs 8 cases, respectively, p > 0.05).
Additionally, there was no difference in the mood states, anxiety levels and perioperative parameters known to
influence the development of POCD.
Conclusions: In this study, the magnitude of the non-infective inflammatory response generated by on-pump cardiac
surgery did not influence the development of POCD in the early postoperative period in elderly patients.
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Background
Postoperative cognitive dysfunction (POCD) is known to
be an important complication of cardiac and non-
cardiac surgeries with marked consequences for the
quality of life, work ability and intermediate-term mor-
tality [1–4]. POCD can be characterized by a combined
or specific impairment of the working memory, execu-
tive function, attention or psychomotor speed [2, 5]. The
manifestation of POCD seems to be independent of age;
however, it varies among age groups in both the inci-
dence and course [5, 6]. While young and middle-aged
patients experience transient cognitive decline, which re-
covers within a short period, the rate of POCD is up to
50% higher in elderly patients for whom the symptoms
are persistent from weeks to months [5–7]. Despite the
relevant amount of data published in this field in the last
two decades, the explicit incidence of POCD remains
debated [8]. This is due to methodological diversities in
the definition of POCD or the neurocognitive tests and
statistical analyses used [1, 8–10]. Hence, the interpreta-
tions of predictors and risk factors of POCD are also un-
clear for the same reasons. However, advanced age and
the extent of surgical trauma are the most established of
all investigated factors [5, 11].
The exact pathogenesis of POCD is unknown.
Nevertheless, it can be supposed that POCD is a
result of interactions between preoperative (patient-
related), perioperative and hospital-associated factors
[2, 5]. There is a strong evidence that inflammation
plays a key role in the development of cognitive
decline and dementia in the elderly. Elevated C-
reactive protein (CRP) and interleukin-6 (IL-6) were
found to be predictors of these in the general popu-
lation [12–15]. The potential causative factors of
POCD, surgical trauma generated inflammatory response
and blood-brain barrier (BBB) disruption have been the
subject of several clinical investigations in cardiac and
non-cardiac surgeries in the past [5, 16, 17]. These studies
confirmed a definitive inflammatory response and BBB
injury after cardiac surgery in both animal and human
investigations [5, 16–18]. However, the direct relation-
ship between inflammatory response and POCD re-
mains controversial [2, 19].
Procalcitonin (PCT) is a widely used biomarker in the
diagnosis and antibiotic treatment of sepsis and its quan-
tification has become the part of clinical practice in this
field in the last 15 years [20, 21]. Nonetheless, PCT
has also been described to be an appropriate indicator
of non-infective postoperative inflammatory response
[22–24], and it may have prognostic value for some
complications related to cardiac surgery [24–26].
The aim of this controlled, prospective observational
study was to assess the association between different grades
of postoperative inflammatory response characterized by
levels of PCT and the frequency of POCD after on-pump
cardiac surgery.
Methods
Subjects
Patients who were aged ≥ 60 years and scheduled for
elective on-pump cardiac surgery were enrolled in the
cardiac surgery group. To create an age-matched, nor-
mative control group, subjects aged ≥ 60 years were re-
cruited from primary care practice. The exclusion
criteria in the cardiac surgery group, as well as in the
normative controls, were significant dementia (Mini
Mental State Examination score < 24), a history of cere-
brovascular disease, intracranial pathology or psychiatric
disease, regular treatment with benzodiazepines or anti-
inflammatory drugs (e.g., steroids or non-steroids), ele-
vated baseline PCT or CRP levels, severe left ventricle
dysfunction (ejection fraction < 35%) or any kind of
organ failure. Surgery or hospitalization within the last
12 months was an additional exclusion criterion in the
control group.
Anaesthetic procedure
Anaesthesia was performed using a midazolam bolus
0.05 mg/kg intravenously (IV), sufentanyl bolus
0.5 μg/kg IV, propofol bolus 1 mg/kg IV, or atracurium
bolus 0.5 mg/kg IV for induction and then propofol
3–5 mg/kg/h continuous IV and sufentanyl boluses for
maintenance of anaesthesia, including the cardiopul-
monary bypass (CPB) period. Intraoperative monitoring
of patients was based on anaesthesia standards extended
with arterial blood pressure, central venous pressure,
nasopharyngeal temperature and a bispectral index (BIS,
Covidien LLC, Mansfield, MA USA) monitor. The depth
of anaesthesia was controlled in range 45–60 of BIS for
the entire surgery. CPB was provided by a roller-pump
(MAQUET HL 20, MAQUET GmbH & Co. KG, Ras-
tatt, Germany) and membrane oxygenator (MAQUET
Quadrox, MAQUET GmbH & Co. KG, Rastatt,
Germany). The components of CPB prime were
1200 mL of Ringer lactate, 100 mL of mannitol, and
60 mL of sodium bicarbonate 8.4%. The non-pulsatile
flow rate of CPB was maintained in the range of 2.2–
2.4 L/min/m2. The mean arterial blood pressure
(MAP) was controlled with noradrenaline or glyceryl
trinitrate to retain the target MAP of 60–80 mmHg
during CPB. Clinical management of anaesthesia and
CPB was based on institutional standards, including
the temperature, metabolic targets (α-stat acid-base
management) and transfusion triggers.
Continuous propofol IV infusion was administered as
postoperative sedation during the mechanical ventilation
period in the intensive care unit (ICU). Postoperative
analgesia consisted of morphine sulphate IV boluses
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adjusted to the patients’ requirements and 1 g of para-
cetamol IV infusion (every 6 h as needed). The treat-
ment of study patients in the ICU and cardiothoracic
surgical ward did not involve benzodiazepine.
Neuropsychological assessment
The assessment of neurocognitive functions was per-
formed on the day before surgery and the seventh post-
operative day in the cardiac surgery group by the
following test battery: Mini Mental State Examination
(MMSE; dementia screening); Trail Making Tests A
and B (TMA and TMB, respectively; executive func-
tions: organized visual search, planning, attention, set
shifting, cognitive flexibility, and divided attention);
Digit Symbol Test (DS; attention, psychomotor speed,
coding task, and visual short-term memory); Stroop
Colour and Word Test (cognitive flexibility and control,
as well as resistance to interference). The Beck Depression
Inventory (BDI; validated in native language [27]) and
State-Trait Anxiety Inventory (STAI; validated in native
language [28]) were used to examine mood states and
anxiety levels at the same time points as the neurocogni-
tive assessment. BDI was only performed preoperatively.
Subjects in the normative control group were examined
and retested after a time interval of 7 days with the same
test battery and protocol. All tests were performed in a
specified room separated from the cardiothoracic surgical
ward and evaluated by one clinical psychologist who was
blinded to the inflammatory status of the patients.
After the collection of test-retest data for each individual,
the within-subject change in the performance on neuro-
cognitive tests was measured using the Reliable Change
Index modified for practice (RCIp) [29]:
RCIp Z score ¼ X2–X1ð Þ−Practice effect
SEdiff
ð1Þ
SEdiff ¼ √ 2 SEmð Þ2
  ð2Þ
SEm ¼ SD1
ffiffiffiffiffiffiffiffiffiffiffi
1−rxx
p  ð3Þ
where rxx is test-retest reliability coefficient, SD1 is the
standard deviation of the baseline score (normative
controls), SEm is the standard error of measurement
(normative controls), SEdiff is the standard error of the
difference (normative controls) [29], X2 is the postoper-
ative test score and X1 is the preoperative test score
(cardiac surgery patients). The practice effect was com-
puted by changes in the mean scores over the test-
retest time interval (normative controls). A significant
change was considered for an RCIp Z score ≥ ± 1.96
(α = 0.05) in all neurocognitive tests, including the
MMSE. POCD was defined by a significant decline in
≥ two neurocognitive tests [10]. The criterion of ≥ 2
scores difference in the MMSE was used to specify the
threshold of significance in the comparison of baseline
cognitions in the three groups [30, 31]. MMSE scores
between 28 and 30 were considered normal cognition,
and the range of 24–27 was considered mild cognitive
impairment [32].
Measurement of inflammatory markers
Venous blood was collected to measure the PCT and
CRP levels at the following six pre-specified time
points: before the operation and then every 24 h
during the first five postoperative days. Blood samples
were analysed using the electrochemiluminescence im-
munoassay (Elecsys BRAHMS PCT, Roche Diagnostics
GmbH, Mannheim, Germany) and particle enhanced
turbidimetric assay (COBAS INTEGRA C-Reactive
Protein Latex, Roche Diagnostics GmbH, Mannheim,
Germany) techniques to quantify the PCT and CRP
levels, respectively. Concentrations greater than
0.5 μg/L PCT and 5.0 mg/L CRP were considered el-
evated levels according to their normal values. The
inflammatory response was defined as “low” for
PCT ≤ 0.5 μg/L or “high” for PCT > 0.5 μg/L mea-
sured on the first postoperative day (POD).
Statistical analysis
Continuous variables were analysed with the Shapiro-
Wilk test for normality. Descriptive statistics are pre-
sented as the mean ± standard deviation for normally
distributed data and the median (interquartile range) for
non-normally distributed data. The unpaired t test and
Mann-Whitney U test were used for comparisons of
group means or medians. The differences in observed
frequencies were determined by the χ2 test and Fischer’s
exact test. Relationships between variables were assessed
using the Spearman correlation test. To justify the sam-
ple size of this study, we calculated the statistical power
of the difference between the two inflammatory re-
sponses post hoc, which was 0.7. Statistical significance
was defined at p < 0.05 by all tests. Analysis was per-
formed with IBM® SPSS Statistics version 23.0 (IBM®
Armonk, NY, USA).
Results
Seventy-four elderly patients with a mean age of 68 ± 6 years
were recruited in the study. The details of patient character-
istics and perioperative parameters can be seen in Table 1
and Table 2. The normative controls (n = 32) and patients
in the cardiac surgery group (n = 42) were similar in base-
line characteristics, including the age, gender and education
(Table 1). Test-retest data of the normative controls used to
calculate the RCIp Z scores are summarized in Table 3. We
found strong test-retest reliability with reliability coeffi-
cients between 0.60 and 0.84. One of five cognitive tests
(i.e., TMB) was not sensitive to practice.
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Based on the a priori definition, cardiac surgery pa-
tients were separated into the low inflammatory re-
sponse (LIR, n = 20) and high inflammatory response
(HIR, n = 22) groups. While the PCT peaked at a level
of 7.71 (3.90–21.52) μg/L on POD1 and then returned
to 0.87 (0.48–2.50) μg/L by POD5 in the HIR group, it
remained within the normal range (PCT ≤ 0.5 μg/L) with
a maximum value of 0.18 (0.11–0.26) μg/L in the LIR
group throughout the postoperative period (Fig. 1a).
CRP reached its highest serum levels between POD2
and POD3 in both the LIR and HIR groups (166.5
(154.6–210.7) mg/L vs 138.1 (115.5–187.6) mg/L,
p = 0.05, respectively) and did not show significant dif-
ferences between the two groups during the first five
postoperative days (Fig. 1b). The white blood cell (WBC)
count had a significantly higher peak value on POD1
in the HIR group compared to the LIR group: 15.0
(11.9–19.5) G/L vs 12.8 (10.8–14.5) G/L, p = 0.012, re-
spectively (Fig. 1c), and it showed a strong correlation
with the PCT level on the first postoperative day in the
HIR group (r = 0.67, p = 0.001). We did not find a
correlation between the peak PCT and peak CRP
values in either the HIR or LIR group (r = 0.10,
p = 0.67 and r = − 0.42, p = 0.06, respectively). There
were no differences between the LIR and HIR groups
in the preoperative statin use, complexity of cardiac sur-
gery, aorta cross-clamp time and CPB time (Table 2).
Seventy-four percent of cardiac surgical patients
(n = 31) had a significantly decreased performance in at
least one cognitive test according to their RCIp Z scores
1 week after surgery. Cognitive flexibility and control
were the most vulnerable tasks to cardiac surgery, as
demonstrated by the Stroop word-colour task results.
Additionally, 38.1% of patients (n = 16) had a significant
decline in this test. Based on the a priori definition of
the POCD (i.e., a significant decline at least in two
neurocognitive tests), 15 of 42 patients (35.7%) met the
criteria of POCD. The RCIp Z scores of each neurocog-
nitive test were similar in the two inflammatory response
groups (Fig. 2). Hence, the frequencies of POCD in the
LIR group did not vary from that in the HIR group
Table 1 Baseline neurocognitive and social characteristics of
the study population and normative control group
Normative controls
(n = 32)
Study subjects
(n = 42)
Age (year)a 68 ± 7 69 ± 6
Gender (n) F / Mb 18 / 14 20 / 22
Education (year)c 14 (9–16) 12 (11–12)
MMSE (score)d 29 (28–30) 28 (27–28)
Data are presented as the mean ± standard deviation, median (interquartile
range) and number of patients
aunpaired t test
bχ2 test and Fischer’s exact test
cMann-Whitney U test. F female, M male, and MMSE Mini Mental State
Examination. There is no significant difference between normative controls
and study subjects regarding age, gender and education
dBased on the a priori criterion of a significant difference in MMSE scores (i.e.,
≥ 2 scores [30, 31]), the median MMSE scores do not differ in the normative
controls and study subjects. Additionally, there is no difference in the baseline
cognition between the two groups
Table 2 Patient characteristics and perioperative clinical data in
the low and high inflammatory response groups
LIR group
n = 20
HIR group
n = 22
Preoperative parameters
Age (year)a 68 ± 6 69 ± 7
Gender (n) F / Mb 9 / 11 11 / 11
Body mass index (kg/m2)c 29.4 (24.7–33.0) 27.2 (25.4–28.8)
Education (year)c 11 (11–12) 12 (11–12)
BDI (score)c 9 (5.3–14.3) 8.0 (5.0–10.0)
STAI-state (score)a 41.9 ± 10.3 41.2 ± 11.4
EuroSCORE (%)c 3.9 (2.8–5.7) 4.3 (2.7–7.6)
HTN (n)b 15 14
DM (n)b 5 6
CAD (n)b 8 9
PVD (n)b 3 2
COPD (n)b 3 4
Left ventricle EF (%)c 55 (55–67) 55 (50–60)
Creatinine (μmol/L)a 74.3 ± 12.6 84.0 ± 21.9
Antihypertensives (n)b 15 14
Statin use (n)b 11 5
Antiplatelet drug (n)b 11 6
Type of surgery
CABG (n)b 6 5
Single valve (n)b 11 13
Combined (n)b 3 4
Intraoperative parameters
Aorta cross-clamp time (minute)a 67 ± 22 64 ± 20
CPB time (minute)a 92 ± 23 91 ± 22
Rewarming time (minute)c 18 (14–22) 17 (10–21)
CPB temperature (°C)c 35.0 (34.7–35.4) 35.2 (34.7–35.5)
Operation time (minute)a 193 ± 27 181 ± 41
Bispectral indexa 44.3 ± 6.0 43.1 ± 5.6
Propofol (mg/kg/h)a 4.1 ± 1.5 4.3 ± 1.3
Sufentanyl (μg/kg/h)c 0.27 (0.2–0.35) 0.28 (0.21–0.3)
The results are presented as the mean ± standard deviation, median
(interquartile range) and number of patients
aunpaired t test
bχ2 test and Fischer’s exact test
cMann-Whitney U test. LIR low inflammatory response, HIR high inflammatory
response, F female, M male, BDI Beck Depression Inventory, STAI State-Trait
Anxiety Inventory, HTN hypertension, DM diabetes mellitus, CAD coronary
artery disease, PVD peripheral vascular disease, COPD chronic obstructive
pulmonary disease, EF ejection fraction, CABG coronary artery bypass graft,
and CPB cardiopulmonary bypass. There are no significant differences between
the two groups regarding all parameters listed in this table
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observed at the first postoperative week (7 cases vs 8
cases, respectively). We did not find differences between
the LIR and HIR groups in the preoperative BDI scores;
pre- and postoperative levels of anxiety; and intraoperative
parameters, including the CPB time, body temperature
on-CPB, rewarming time on-CPB, operation time, BIS
values, propofol and sufentanyl requirements (Table 2).
We registered similar postoperative ventilation times
in the two inflammatory response groups, LIR: 5.3
(4.4–8.3) hour vs HIR: 5.7 (3.3–7.9) hour, p = 0.60 and
the morphine requirement during the first 24 h were
also comparable, LIR: 0.11 (0–0.2) mg/kg vs HIR: 0.11
(0–0.3) mg/kg, p = 0.38. Infection or sepsis and delirium
did not develop among cardiac surgical patients in the
postoperative period. Details of the postoperative outcome
are summarized in Table 4.
Discussion
This study was designed to explore whether the grade of
postoperative non-infective inflammatory response gen-
erated by CPB surgery directly affects the development
of POCD. We distinguished between two different in-
flammatory response levels (i.e., LIR and HIR) of our
elderly patients and applied a strict definition of POCD
based on statistical change criteria. With the exclusion
of confounding factors, our study did not find a direct
relationship between the magnitude of non-infective in-
flammatory response and incidence of POCD.
Defining the inflammatory response related to cardiac
surgery
Cardiac surgery is frequently accompanied by non-infective
systemic inflammatory response syndrome (SIRS) induced
by surgical trauma, CPB, organ ischaemia-reperfusion in-
juries, a change in the body temperature and endotoxin
release [33, 34]. This genetically influenced, complex in-
flammatory process – depending on its magnitude –
can result in multi-organ dysfunction, increasing the
risk of mortality in the postoperative period [33, 35, 36].
Numerous inflammatory mediators have been investigated
to characterize the inflammatory responses related to car-
diac surgery with the purpose of using them as prognostic
markers of the complications and outcome [37]. PCT is
one of the accepted and widely used inflammatory
markers, and it is also applied for follow-up in the cardiac
surgery setting [24, 25]. Its use is based on the assumption
that proinflammatory cytokines can contribute to PCT in-
duction after surgery [24, 26]. In the case of non-infective
SIRS, the PCT concentration increases in the first 24–48 h
after cardiac surgery up to its maximum level and returns
to the baseline range in the subsequent days [24, 26]. The
peak level of PCT seems to be associated with the extent
of surgical procedure, duration of aortic cross-clamp and
CPB, and the length of operation [24]. Constantly elevated
PCT levels in the postoperative period suggest ongoing in-
flammation due to a possible septic process [20, 24, 38].
In our study, we followed up PCT as a primary and
CRP as a secondary inflammatory marker to distinguish
the grade of the inflammatory response in the periopera-
tive period. We observed significant differences in the
magnitudes of PCT changes in the individuals who were
clearly isolated to the LIR and HIR groups. While the
main characteristics of the PCT time course in the HIR
group were consistent with previous reports as it
reached a peak value at 7.71 μg/L on POD1 [35, 38–40],
PCT did not exceed the cut-off value of 0.5 μg/L at any
time-point in the LIR group (Fig. 1a). Despite the mark-
edly divergent PCT kinetics in the LIR and HIR groups,
they did not differ in the perioperative parameters that
are supposed to influence the inflammatory response
and course, such as the preoperative statin use, duration
of aortic cross-clamp and CPB, length of operation,
propofol requirements, number of transfusions and post-
operative infection [33, 41–44] (Table 2). We also
investigated the possible factors of immune priming.
Coexisting chronic diseases, such as diabetes mellitus
(DM) or peripheral vascular disease (PVD), are fre-
quently accompanied by a pro-inflammatory state, which
possibly amplifies the inflammatory response in the
postoperative period [2]. However, our comparative ana-
lysis did not show differences in DM and PVD between
the LIR and HIR groups. These results are similar to the
findings of previous studies [36, 45], supporting that an
evolving complex inflammatory response to stimuli of
CPB surgery is primarily determined by the individual
reactivity of cytokines and the proinflammatory-anti-
inflammatory balance. In the present study, we found a
completely different behaviour of the CRP level com-
pared to PCT. The results published elsewhere show
that CRP increases after cardiac surgery irrespective of the
extent of the surgery or presence of SIRS [24, 26, 39]. This
fact makes the interpretation of the CRP time course
Table 3 Statistical parameters of the Reliable Change Index
modified for practice measured in normative controls
Cognitive test rxx PE SEdiff
MMSE 0.66 0.5*** 0.9
TMA 0.71 −7.6** 14.0
TMB 0.60 −9.0 29.1
DS 0.81 2.5* 6.1
Stroop W 0.66 1.6*** 5.7
Stroop C 0.84 3.0*** 4.8
Stroop CW 0.80 5.1*** 5.2
rxx test-retest reliability coefficient, PE practice effect, and SEdiff standard error
of the difference. The significance of PE was tested using paired t test. *p < 0.05;
**p < 0.01, and ***p < 0.001; MMSE Mini Mental State Examination, TMA Trail
Making Test A, TMB Trail Making Test B, DS Digit Symbol test, Stroop W Stroop
word task, Stroop C Stroop colour task and Stroop CW Stroop colour-word task
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uncertain. Our results agree with these findings because
the peak CRP did not correlate with peak PCT, and it was
markedly elevated in all subjects of the cohort and did not
vary between the LIR and HIR groups during the postop-
erative period. Interestingly, the WBC count did correlate
with PCT rather than with CRP in the HIR group. Hence,
our data confirm that PCT follow-up is appropriate to
discriminate the grade of the non-infective inflammatory
response related to cardiac surgery.
Role of the inflammatory response in the development of
POCD after cardiac surgery
The occurrence of POCD was 35.7% in this study based
on RCIp analysis [29] of neurocognitive tests and the def-
inition of decline in at least two tests. Instead of frequently
used fixed cut-off methods (i.e., 20% or 1–2 SD change)
[8, 29], we applied RCIp involving the age-matched
healthy non-surgical control group to determine the
incidence of POCD. RCIp employs statistical change cri-
teria –corrected for measurement error and mean practice
effect– to estimate the valid change of performance on a
neurocognitive test [8, 29, 46]. There are only a few com-
parable publications in the literature that apply statistical
change criteria methods in a cardiac surgery setting
[29, 47–49]. The observed POCD incidence in our
elderly group of patients is in line with their findings
(36 vs 33–43%, respectively), which supports the con-
clusion of a recent investigation of Raymond et al. [29]
Analyses that use statistical change criteria can consider-
ably contribute to valid estimation of POCD as they
minimize the risk of both overestimation and underesti-
mation of decline in the test performance [8, 29].
Fig. 2 RCIp Z scores of neurocognitive tests. Z score means are demonstrated with a blank bar in the low inflammatory response group and
striped bar in the high inflammatory response group. Error bars represent the standard error of the mean. The limit of the significant decline in
performance is indicated by a continuous line at RCIp Z score of −1.96. None of the neurocognitive tests showed a significant decline at the
group level. The RCIp Z scores were similar in the two inflammatory response groups, except the Stroop word task, based on the Mann-Whitney
U test. Significant differences between the LIR and HIR groups are demonstrated with asterisks: *p < 0.05. MMSE = Mini Mental State Examination;
TMA = Trail Making Test A; TMB = Trail Making Test B; DS = Digit Symbol test; Stroop W = Stroop word task; Stroop C = Stroop colour task; and
Stroop CW = Stroop colour-word task
(See figure on previous page.)
Fig. 1 Changes in the procalcitonin (a), C-reactive protein (b) and white blood cell count (c) levels during the postoperative period. A continuous
line demonstrates low inflammatory response (LIR) and a dotted line shows the high inflammatory response (HIR) group. Spots and error bars
represent the medians and 95% confidence intervals. Significant differences between the LIR and HIR groups are demonstrated with asterisks:
***p < 0.001, Mann-Whitney U test
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The main result of this study was that a direct rela-
tionship has not been revealed between the degree of
PCT elevation and decline in any neurocognitive test or
early POCD. The secondary analysis of our data vali-
dated this result as perioperative mood states, and pre-
disposing factors of POCD [2, 6, 47, 50] were similar in
the two inflammatory response groups defined by the
PCT levels (Tables 2 and 4). Furthermore, we did not
observe postoperative complications that affect cognitive
function. Numerous investigations have focused on the
link between proinflammatory cytokines and cognitive
dysfunction related to cardiac surgery in the last two de-
cades [2, 17]. Using animal models, Cibelli et al. [51] and
Terrando et al. [52] described a potential link between
systemic and hippocampal inflammation through the
TNF-α, IL-1β and NF-κB pathways, and the impairment
of memory as a consequence of the former processes.
Jungwirth et al. also confirmed significant cerebral ex-
pression of NF-κB in the hippocampus after CPB surgery
in a high-quality randomized controlled animal study;
however, it was not associated with the neurocognitive
outcome [53]. Clinical trials applying arbitrary cut-off
criteria for POCD definition in either the cardiac or
non-cardiac surgery setting concluded conflicting results
on the relationship between pro-inflammatory cytokines
and POCD [54–56]. In a recent investigation of elective
coronary artery bypass patients, Hudetz et al. demon-
strated that short- and medium-term cognitive dysfunc-
tion was related to elevated postoperative IL-6 and CRP
levels [57]. Their results were based on the POCD
definition involving data from the normative population
and Z score [57]. By contrast, most recently published
large randomized clinical trials have conflicting results
on the incidence of POCD or postoperative delirium
when they used pharmacological anti-inflammatory
treatment (i.e., dexamethasone or methylprednisolone)
during non-cardiac and cardiac surgery [19, 58, 59]. This
result might strengthen earlier assumptions that factors
other than the grade of the inflammatory response play
key role in the pathogenesis of POCD [53, 56]. Our re-
sults support this concept because we could clearly dem-
onstrate that the incidence of POCD measured in this
study does not depend on the magnitude of the inflam-
matory response.
Limitations
Our investigation has several limitations. First, the study
was conducted in a single centre, which influenced the
sample size over the study period. The description of the
postoperative inflammatory response was based on the
PCT, CRP and WBC count measurements, and we did
not involve pro-inflammatory cytokines in the analysis
for further specifications. Our study did not strictly ad-
here to the Statement of Consensus on Assessment of
Neurobehavioral Outcomes after Cardiac Surgery [60] in
terms of the applied neurocognitive tests. This study was
designed for the short interval outcome measure that
aimed to assess the early changes in cognitive function
after cardiac surgery, which restricts the interpretation
of our results. Considering the post hoc statistical power
of this observational study, our presented results are
preliminary results, while these data are not confirmed
by further investigations.
Conclusions
Despite the significant difference in the magnitude of
the non-infective inflammatory response induced by
CPB surgery, the incidence of POCD was similar in the
LIR and HIR groups of our elderly patients when POCD
was measured in a strict methodological framework. The
role of the inflammatory response in the pathogenesis of
POCD needs to be cleared by further investigations.
Abbreviations
BBB: Blood-brain barrier; BDI: Beck Depression Inventory;
CPB: Cardiopulmonary bypass; CRP: C-reactive protein; DM: Diabetes mellitus;
DS: Digit Symbol Test; HIR: High inflammatory response; ICU: Intensive Care
Unit; IL-6: Interleukin-6; IV: Intravenously; LIR: Low inflammatory response;
MAP: Mean arterial pressure; MMSE: Mini Mental State Examination;
PCT: Procalcitonin; POCD: Postoperative cognitive dysfunction;
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error of measurement; SIRS: Systemic inflammatory response syndrome;
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Table 4 Postoperative outcome parameters in the low and
high inflammatory response groups
LIR group (n = 20) HIR group (n = 22)
Ventilation time (hour)a 5.3 (4.4–8.3) 5.7 (3.3–7.9)
Transfused patients (n)b 6 6
PRC (unit)a 0 (0) 0 (0–1)
Respiratory failure (n)b 3 2
New onset AF(n)b 5 4
Acute kidney injury (n)b 2 5
STAI-state (score)c 36.7 ± 8.8 38.2 ± 8.1
POCD (n)b 7 8
Length-of-ICU-stay (hour)a 24 (24–46) 23 (22–60)
Length-of-hospital-stay (day)a 10 (8–17) 11 (9–13)
In-hospital death (n) 0 0
Data are presented as the median (interquartile range), number of patients
and mean ± standard deviation
aMann-Whitney U test
bχ2 test and Fischer’s exact test
cunpaired t test; LIR low inflammatory response, HIR high inflammatory
response, PRC packed red cells, AF atrial fibrillation, STAI State-Trait Anxiety
Inventory, POCD postoperative cognitive dysfunction, and ICU intensive care
unit. There are no significant differences between the two groups regarding all
parameters listed in this table
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